WST - West Pharmaceutical Services, Inc.
| Previous Close | 120.10 |
| Open | 120.03 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1300 |
| Day's Range | 120.03 - 121.99 |
| 52 Week Range | 82.74 - 122.00 |
| Volume | 503,262 |
| Avg. Volume | 354,533 |
| Market Cap | 8.942B |
| Beta | 1.26 |
| PE Ratio (TTM) | 60.86 |
| EPS (TTM) | 2.00 |
| Earnings Date | Oct 24, 2018 - Oct 29, 2018 |
| Forward Dividend & Yield | 0.56 (0.46%) |
| Ex-Dividend Date | 2018-07-17 |
| 1y Target Est | 104.43 |
Markit•19 days agoSee what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc NYSE:WST
- Simply Wall St.•23 days ago
Is West Pharmaceutical Services Inc’s (NYSE:WST) PE Ratio A Signal To Sell For Investors?
I am writing today to help inform people who are new to the stock market and want to begin learning about how to value company based on its current earningsRead More...
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of WST earnings conference call or presentation 26-Jul-18 1:00pm GMT
Q2 2018 West Pharmaceutical Services Inc Earnings Call
- Associated Press•2 months ago
West Pharmaceutical: 2Q Earnings Snapshot
The Exton, Pennsylvania-based company said it had profit of 75 cents per share. Earnings, adjusted for pretax gains, were 70 cents per share. The results surpassed Wall Street expectations. The average ...
- PR Newswire•2 months ago
West Announces Second-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter ...
- PR Newswire•2 months ago
West Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering
EXTON, Pa., July 19, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West's advanced manufacturing network, and the launch of a new product line—Westar® Select. Customers and senior-level Irish government officials joined West at a ribbon-cutting ceremony to celebrate the facility's opening and to recognize West's ongoing commitment to improving patient lives through their products and services. "West is very pleased to celebrate the official opening of our state-of-the-art facility in Waterford, as well as the launch of Westar Select, both of which are the culmination of efforts by many to support our company's commitment to meeting the dynamic needs of our pharmaceutical and biotech partners," said Eric Green, President and CEO, West.
- CNBC•2 months ago
Cramer's lightning round: Cigna's stock is undervalued considering its latest acquisition
It's that time again! "Mad Money" host Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed. Cigna Corporation CI : “OK, when [CEO] David Cordani came on, the stock was right around here. Sociedad Quimica y Minera de Chile S.A SQM-X.A-CL .: “Sociedad Quimica is not an expensive stock if lithium takes off.
- PR Newswire•2 months ago
West to Host Second-Quarter 2018 Conference Call
EXTON, Pa. , July 12, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release ...
- Simply Wall St.•3 months ago
Why Wistil Spólka Akcyjna (WSE:WST) Should Have A Place In Your Portfolio
Wistil Spólka Akcyjna (WSE:WST) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In theRead More...
- Simply Wall St.•3 months ago
West Pharmaceutical Services Inc (NYSE:WST): Should The Recent Earnings Drop Worry You?
Examining West Pharmaceutical Services Inc’s (NYSE:WST) past track record of performance is a valuable exercise for investors. It enables us to understand whether the company has met or exceed expectations,Read More...
- PR Newswire•3 months ago
West Appoints Bernard Birkett to Chief Financial Officer
EXTON, Pa., June 21, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Bernard J. Birkett to serve as Senior Vice President, Chief Financial Officer and Treasurer, effective June 21, 2018. Mr. Birkett will succeed William J. Federici, who announced in March his intention to retire later this year. Mr. Birkett joins West from Merit Medical Systems, Inc., a leading manufacturer of disposable medical devices, where he most recently served as Chief Financial Officer and Treasurer.
- PR Newswire•3 months ago
West's SelfDose™ Patient-Controlled Injector Wins Silver Medical Design Excellence Award
EXTON, Pa., June 13, 2018 /PRNewswire/ -- (Booth #1933) -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the Silver Medical Design Excellence Award for "Drug-Delivery and Combination Products" for its SelfDose™ Patient-Controlled Injector. The honor was presented to West and its customer Accord Healthcare Limited, which uses the SelfDose patient-controlled injector technology with its Methofill™ (methotrexate) SELF INJECT, on June 12, 2018 at the MD&M East Conference in New York City. Organized by Medical Device and Diagnostic Industry magazine, the annual Medical Design Excellence Awards (MDEA) competition recognizes significant achievements in medical product design and engineering and the many people behind the scenes—engineers, scientists, designers and clinicians—who are responsible for the cutting-edge products that are improving patient healthcare.
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of WST earnings conference call or presentation 26-Apr-18 1:00pm GMT
Q1 2018 West Pharmaceutical Services Inc Earnings Call
- ACCESSWIRE•3 months ago
Complimentary Technical Snapshots on TransEnterix and Three More Medical Supplies Stocks
LONDON, UK / ACCESSWIRE / June 11, 2018 / If you want a free Stock Review on TRXC sign up now at www.wallstequities.com/registration. Today's attention is redirected to the Medical Instruments and Supplies space, which comprises companies that manufacture and sell medical devices, instrument systems, and reagents and consumables.
- PR Newswire•4 months ago
West Announces Participation in Upcoming June Investor Conferences
EXTON, Pa. , May 24, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management ...
- PR Newswire•5 months ago
West Announces Third-Quarter Dividend, Increase to Fourth-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa., May 3, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST) today announced that the Company's Board of Directors has approved a third-quarter 2018 dividend of $0.14 per share. The dividend will be paid on August 1, 2018, to shareholders of record as of July 18, 2018. In addition, the Board of Directors has approved a fourth-quarter dividend of $0.15 per share, a 7.1% increase over the $0.14 per share declared for each of the four preceding quarters. This is the twenty-sixth consecutive annual increase in the Company's dividend. The fourth-quarter dividend will be paid on November 7, 2018, to shareholders of record as of October 24, 2018.
- ACCESSWIRE•5 months ago
West Pharmaceutical Services, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / April 26, 2018 / West Pharmaceutical Services, Inc. (NYSE: WST ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 26, 2018 at 9:00 AM ...
- Associated Press•5 months ago
West Pharmaceutical: 1Q Earnings Snapshot
The Exton, Pennsylvania-based company said it had net income of 58 cents per share. Earnings, adjusted for restructuring costs and pretax expenses, were 62 cents per share. The results missed Wall Street ...
- PR Newswire•5 months ago
West Announces First-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter ...
- ACCESSWIRE•5 months ago
EX-Dividend Schedule: Has Raised Dividend for 25 Consecutive Years; Will Trade Ex-Dividend on April 17, 2018
LONDON, UK / ACCESSWIRE / April 16, 2018 / Active-Investors has a free review on West Pharmaceutical Services, Inc. (NYSE: WST ) following the Company's announcement that it will begin trading ex-dividend ...
- PR Newswire•5 months ago
West to Host First-Quarter 2018 Conference Call
EXTON, Pa., April 12, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2018 financial results before the market opens on Thursday, April 26, 2018, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 9889627.
Markit•5 months agoSee what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc NYSE:WST
- PR Newswire•6 months ago
West to Showcase DAIKYO PLASCAP® RUV One-Step Press-Fit Vial Closure Solution at PDA Annual Meeting
West to present several scientific posters highlighting expertise in ensuring quality, sterility and stability of injectable drug products ORLANDO, Fla. , March 19, 2018 /PRNewswire/ -- (Booth #501) – ...
